Apply

Ready to go for it?

AI Apply speeds things up—apply directly if you prefer.

FREE ACCESS
5,000–10,000 jobs/day
Scoutfield Logo

See all jobs on Scoutfield

Search thousands of fresh jobs every day.

Discover
  • Fresh listings
  • Fast filters
  • No subscription required
Create a free account and start exploring right away.
Pulmovant

Associate Director, Drug Substance

Pulmovant

. Drive late-stage drug substance development, scale-up, and commercial manufacturing .

Posted 9/24/2026full-timeRemote • United StatesSeniorWebsite

Core Competencies

Role fit
Core Competencies

Use this summary to align your resume positioning with the role.

Demonstrates expertise in late-stage drug substance development, scale-up, and commercial manufacturing, with a strong focus on regulatory compliance and process optimization. Proven ability to lead cross-functional teams and manage CDMO relationships while ensuring adherence to global cGMP standards.

Highest-signal resume keywords
Ph.D. Or M.S. In Organic Chemistry8+ Years In Drug Substance DevelopmentProcess Development And Scale-UpQuality By Design (QbD)Regulatory Compliance And cGMP

ATS Keywords

Tailor your resume
Applicant Tracking System Keywords

Tip: use these terms in your resume and cover letter to boost ATS matches.

Hard Skills
Drug Substance DevelopmentScale-Up ProcessesTechnical TransferProcess ValidationCritical Process ParametersImpurity ProfilingSolid-State CharacterizationNDA Submission SupportPre-Approval Inspection ManagementICH Guidelines
Soft Skills
Project ManagementOrganizational SkillsLeadership SkillsCommunication SkillsInfluencing Stakeholders
Tools & Technologies
SsNMRXRPDAdvanced Spectroscopic Techniques
Industry Keywords
Pharmaceutical IndustryCDMO RelationshipsCGMP ComplianceRegulatory BodiesInhaled Products

About the role

Key responsibilities & impact
  • Drive late-stage drug substance development, scale-up, and commercial manufacturing
  • Partner with internal CMC, Regulatory, and Quality teams to design, optimize, and define robust, scalable drug substance processes
  • Direct optimization and scale-up of manufacturing processes at external partners
  • Apply Quality by Design (QbD) and Design of Experiments (DoE) methodologies to establish Critical Process Parameters and Critical Quality Attributes
  • Lead technical transfer of drug substance processes across global CDMOs
  • Lead scale-up activities and process validation campaigns in alignment with FDA, EMA, and other regulatory bodies
  • Oversee commercial-scale manufacturing lines, process consistency, yield optimization, and supply robustness
  • Ensure compliance with global cGMP and regulatory standards
  • Establish drug substance control strategies, including impurity profiling and Proven Acceptable Ranges per ICH guidelines
  • Support authoring and review of CMC sections for global regulatory submissions and responses to agency inquiries
  • Collaborate with internal and external stakeholders and report to the Sr. Director of Drug Substance Development

Requirements

What you’ll need
  • Ph.D. or M.S. in Organic Chemistry, Chemical Engineering, Pharmaceutical Sciences, or a closely related discipline
  • 8+ years of progressive experience in drug substance development and manufacturing within the pharmaceutical industry, focusing on late-stage development and commercialization
  • Strong background in managing CDMO relationships and outsourcing strategies
  • Demonstrated experience in process development, scale-up, and technical transfer
  • Knowledge of global regulatory requirements and cGMP compliance
  • Excellent project management, organizational, and leadership skills
  • Ability to work in a fast-paced, cross-functional environment and influence internal and external stakeholders
  • In-depth knowledge of material sciences and solid-state characterization, including ssNMR, XRPD, and advanced spectroscopic techniques
  • Strong written and verbal communication skills
  • Proven, hands-on experience driving drug substance chemistry, manufacturing, and control (CMC) activities directly supporting a successful NDA submission
  • Prior experience preparing for, hosting, or managing a successful regulatory Pre-Approval Inspection (PAI)
  • Recognized Subject Matter Expert in late-stage process characterization, including QbD, PAR/NOR establishment, Fate and Purge of impurities studies, and ICH M7/nitrosamine safety assessments
  • Highly fluent and well-versed in global ICH guidelines for drug substance development and manufacturing
  • Experience with inhaled/inhalation products is a plus